NAFDAC moves to intensify war against sub-standard, falsified medicines

The National Agency for Food and Drug Administration and Control (NAFDAC) will intensify the fight against substandard and falsified medicines in the country with the implementation of pharmaceutical traceability strategy to safeguard the health of the Nigerian populace.

The Director-General, Mojisola Adeyeye, stated this at at a workshop in Portharcourt, organised by the agency while finalising the draft traceability of pharmaceutical products regulations.

This is contaed in a statement signed by the NAFDAC spokesperson, Mr Olusayo Akintola in Abuja.

Adeyeye said: ”the task of safeguarding the health of the nation is daunting in the face of the chaotic drug distribution system currently existing in Nigeria”.

She said that the falsification and diversion of health commodities caused serious health and economic consequences.

“The consequences vis-à-vis the mandate of the agency to regulate and control among other things, the distribution of drugs and other regulated products is sufficient motivation for the implementation of pharmaceutical traceability,” she said.

The director-general said there is need to complement the fight against the menace of substandard and falsified medicines and improve the regulatory control of the medicines supply chain in Nigeria.

She said that NAFDAC was committed to the full implementation of pharmaceutical traceability in Nigeria as part of regulatory strengthening and underscoring its mandate.

Adeyeye also said that NAFDAC has developed a five-Year traceability implementation plan in line with the objectives of the Nigeria pharmaceutical traceability strategy.

She said the idea is aimed at achieving supply chain visibility and strengthening interventions against substandard and falsified medicines by the end of her second term.

”Gazetting and dissemination of the traceability of pharmaceutical products and regulations is essential for the adoption and enforcement of the provisions of the Nigeria pharmaceutical traceability strategy.